Ephylone

Ephylone (N-ethylpentylone, bk-ethyl-K), also known as 5-EAPB analog or β-keto-ethyl-K, is a synthetic cathinone of the MDxx class combining entactogenic and stimulant properties. It is the N-ethyl analog of pentylone (bk-MBDP) and a structural member of the N-alkyl-methylenedioxypentiophenone family, placing it in the same chemical neighborhood as ethylone, methylone, and butylone.

Ephylone's pharmacological profile combines serotonin, dopamine, and norepinephrine activity consistent with other MDxx cathinones, producing experiences that blend entactogenic qualities (emotional openness, sociability enhancement) with stimulant effects (energy, focus, euphoria). Like other cathinones with methylenedioxy substitution, ephylone shares a structural motif with MDMA and produces a qualitatively similar but pharmacologically distinct experience — the empathogenic warmth is typically described as milder than MDMA, with more prominent stimulant character.

The duration of ephylone is relevant to its harm profile: like other cathinones, it tends toward shorter duration than the corresponding non-beta-ketone phenethylamines, with primary effects lasting 2–4 hours. This shorter duration contributes to the redosing cycle characteristic of cathinone use. Community accounts of ephylone functional use emphasize its utility for productivity and social enhancement at controlled doses, with a harm reduction emphasis on avoiding frequency escalation.

Ephylone is substantially understudied, emerging in drug early warning systems in multiple jurisdictions in the 2010s. As with other under-characterized NPS cathinones, extrapolation from structurally related and better-characterized compounds provides the principal basis for harm assessment. All MDxx cathinone harm reduction guidance — including the strict avoidance of MAOI combinations and the precautionary spacing of use — applies to ephylone.